Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization

Abstract Background Prior research showed that elevated serum uric acid (SUA) levels in women with polycystic ovary syndrome (PCOS) before in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) treatment can lead to a lower rate of live birth and an increased risk for low birthweight....

Full description

Saved in:
Bibliographic Details
Main Authors: Leizhen Xia, Lu Fan, Jialyu Huang, Yan Zhao, Lifeng Tian, Houyang Chen, Li Cai, Qiongfang Wu, Leixiang Xia
Format: Article
Language:English
Published: BMC 2024-11-01
Series:Reproductive Biology and Endocrinology
Subjects:
Online Access:https://doi.org/10.1186/s12958-024-01313-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162719393579008
author Leizhen Xia
Lu Fan
Jialyu Huang
Yan Zhao
Lifeng Tian
Houyang Chen
Li Cai
Qiongfang Wu
Leixiang Xia
author_facet Leizhen Xia
Lu Fan
Jialyu Huang
Yan Zhao
Lifeng Tian
Houyang Chen
Li Cai
Qiongfang Wu
Leixiang Xia
author_sort Leizhen Xia
collection DOAJ
description Abstract Background Prior research showed that elevated serum uric acid (SUA) levels in women with polycystic ovary syndrome (PCOS) before in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) treatment can lead to a lower rate of live birth and an increased risk for low birthweight. Nonetheless, it is not known whether elevated SUA results in similar reproductive outcome in women without PCOS. This study aimed to exploring the relationship between pre-pregnancy SUA levels and reproductive outcomes in non-PCOS women undergoing IVF/ICSI treatment. Methods This single-center, retrospective study included 13,325 women without PCOS undergoing their first IVF/ICSI fresh embryo transfer cycles from January 2014 to December 2022 at a university-affiliated reproductive medicine center in China. The trends for pregnancy, obstetric and perinatal outcomes across quartiles of SUA levels were assessed. A logistic regression analysis was applied to control for baseline and cycle characteristics. Generalized addition model was used to draw spline smoothing plot. Results There was no significant decreasing or increasing trend in the clinical pregnancy rate and live birth rate with the increase in quartiles of SUA levels. For Obstetric and perinatal outcomes following a single live birth, the percentage of hypertensive disorders in pregnancy (1.6–4.1%, P trend<0.001), gestational diabetes mellitus (5.9–13.9%, P trend<0.001), premature rupture of membranes (0.6–1.5%, P trend=0.016), preterm birth (6.3–9.2%, P trend=0.009), macrosomia (2.3–5.5%, P trend<0.001), large for gestational age (10.8–14.9%, P trend=0.002) all increased significantly from the lowest quartile to the highest. Logistic regression results showed that compared with those in quartile 1, the risk of maternal and infant complications mentioned above was still significantly higher in quartile 4 after adjusting for reproductive related factors. When further confounding factors were added, including body mass index (BMI), blood pressure, fasting blood glucose, and blood lipids related indicators, only gestational diabetes mellitus and macrosomia showed a significant increase. Conclusion In women without PCOS, SUA levels before IVF/ICSI treatment do not affect the probabilities of clinical pregnancy and live birth. An elevated SUA level is associated with an increased risk for hypertensive disorders in pregnancy, gestational diabetes mellitus, premature rupture of membranes, preterm birth, macrosomia, and large for gestational age. For gestational diabetes mellitus and macrosomia, the association is independent of BMI, blood pressure, blood glucose, and blood lipid.
format Article
id doaj-art-8218f0248aca4a089df35eeca5e2942f
institution OA Journals
issn 1477-7827
language English
publishDate 2024-11-01
publisher BMC
record_format Article
series Reproductive Biology and Endocrinology
spelling doaj-art-8218f0248aca4a089df35eeca5e2942f2025-08-20T02:22:29ZengBMCReproductive Biology and Endocrinology1477-78272024-11-0122111310.1186/s12958-024-01313-8Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilizationLeizhen Xia0Lu Fan1Jialyu Huang2Yan Zhao3Lifeng Tian4Houyang Chen5Li Cai6Qiongfang Wu7Leixiang Xia8Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeDepartment of Child Health, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital Affiliated to Nanchang Medical CollegeDepartment of Acupuncture, the Affiliated Hospital of Jiangxi University of Traditional Chinese MedicineAbstract Background Prior research showed that elevated serum uric acid (SUA) levels in women with polycystic ovary syndrome (PCOS) before in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI) treatment can lead to a lower rate of live birth and an increased risk for low birthweight. Nonetheless, it is not known whether elevated SUA results in similar reproductive outcome in women without PCOS. This study aimed to exploring the relationship between pre-pregnancy SUA levels and reproductive outcomes in non-PCOS women undergoing IVF/ICSI treatment. Methods This single-center, retrospective study included 13,325 women without PCOS undergoing their first IVF/ICSI fresh embryo transfer cycles from January 2014 to December 2022 at a university-affiliated reproductive medicine center in China. The trends for pregnancy, obstetric and perinatal outcomes across quartiles of SUA levels were assessed. A logistic regression analysis was applied to control for baseline and cycle characteristics. Generalized addition model was used to draw spline smoothing plot. Results There was no significant decreasing or increasing trend in the clinical pregnancy rate and live birth rate with the increase in quartiles of SUA levels. For Obstetric and perinatal outcomes following a single live birth, the percentage of hypertensive disorders in pregnancy (1.6–4.1%, P trend<0.001), gestational diabetes mellitus (5.9–13.9%, P trend<0.001), premature rupture of membranes (0.6–1.5%, P trend=0.016), preterm birth (6.3–9.2%, P trend=0.009), macrosomia (2.3–5.5%, P trend<0.001), large for gestational age (10.8–14.9%, P trend=0.002) all increased significantly from the lowest quartile to the highest. Logistic regression results showed that compared with those in quartile 1, the risk of maternal and infant complications mentioned above was still significantly higher in quartile 4 after adjusting for reproductive related factors. When further confounding factors were added, including body mass index (BMI), blood pressure, fasting blood glucose, and blood lipids related indicators, only gestational diabetes mellitus and macrosomia showed a significant increase. Conclusion In women without PCOS, SUA levels before IVF/ICSI treatment do not affect the probabilities of clinical pregnancy and live birth. An elevated SUA level is associated with an increased risk for hypertensive disorders in pregnancy, gestational diabetes mellitus, premature rupture of membranes, preterm birth, macrosomia, and large for gestational age. For gestational diabetes mellitus and macrosomia, the association is independent of BMI, blood pressure, blood glucose, and blood lipid.https://doi.org/10.1186/s12958-024-01313-8Uric acidIn vitro fertilizationLive birthObstetric outcomesPerinatal outcomes
spellingShingle Leizhen Xia
Lu Fan
Jialyu Huang
Yan Zhao
Lifeng Tian
Houyang Chen
Li Cai
Qiongfang Wu
Leixiang Xia
Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
Reproductive Biology and Endocrinology
Uric acid
In vitro fertilization
Live birth
Obstetric outcomes
Perinatal outcomes
title Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
title_full Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
title_fullStr Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
title_full_unstemmed Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
title_short Effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
title_sort effect of serum uric acid level on reproductive outcome in women without polycystic ovary syndrome undergoing in vitro fertilization
topic Uric acid
In vitro fertilization
Live birth
Obstetric outcomes
Perinatal outcomes
url https://doi.org/10.1186/s12958-024-01313-8
work_keys_str_mv AT leizhenxia effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT lufan effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT jialyuhuang effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT yanzhao effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT lifengtian effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT houyangchen effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT licai effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT qiongfangwu effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization
AT leixiangxia effectofserumuricacidlevelonreproductiveoutcomeinwomenwithoutpolycysticovarysyndromeundergoinginvitrofertilization